Lactobacillus casei Alters hPEPT1-Mediated Glycylsarcosine Uptake in Caco-2 Cells

Journal of Nutrition

Volumn 134, Issue 5, 2004, Pages 1120-1123

  Neudeck, Brien L ^a   Loeb, Jennifer M ^a   Faith, Nancy G ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Caco 2 cells; Glycylsarcosine; hPEPT1; Lactobacillus casei

Indexed keywords

CARRIER PROTEIN; GLYCYLSARCOSINE; MESSENGER RNA;

CELL STRAIN CACO 2; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LACTOBACILLUS CASEI; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

LACTOBACILLUS; LACTOBACILLUS CASEI;

EID: 2442604763     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.5.1120     Document Type: Conference Paper

References (23)

1. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. & De Simone, C. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.
2. Alvarez-Olmos, M. I. & Oberhelman, R. A. (2001) Probiotic agents and infectious diseases: a modem perspective on a traditional therapy. Clin. Infect. Dis. 32: 1567-1576.
3. Shornikova, A. V., Casas, I. A., Isolauri, E., Mykkanen, H. & Vesikari, T. (1997) Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24: 399-404.
4. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M. & Campieri, M. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
5. Vignolo, G., Palacios, J., Farias, M. E., Sesma, F., Schillinger, U., Holzapfel, W. & Oliver, G. (2000) Combined effect of bacteriocins on the survival of various Usteria species in broth and meat system. Curr. Microbiol. 41: 410-416.
6. Mack, D. R., Michail, S., Wei, S., McDougall, L. & Hollingsworth, M. A. (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276: G941-G950.
7. Gopal, P. K., Prasad, J., Smart, J. & Gill, H. S. (2001) In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 67: 207-216.
8. Mattar, A. F., Teitelbaum, D. H., Drongowski, R. A., Yongyi, F., Harmon, C. M. & Coran, A. G. (2002) Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 18: 586-590.
9. Michail, S. & Abernethy, F. (2002) Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J. Pediatr. Gastroenterol. Nutr. 35: 350-355.
10. Borruel, N., Casellas, F., Antolin, M., Llopis, M., Carol, M., Espiin, E., Naval, J., Guarner, F. & Malagelada, J. R. (2003) Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am. J. Gastroenterol. 98: 865-870.
11. Bai, P. F., Subramanian, P., Mosberg, H. I. & Amidon, G. L. (1991) Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group. Pharm. Res. 8: 593-599.
12. Dantzig, A. H. & Bergin, L. (1988) Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun. 155: 1082-1087.
13. Thwaites, D. T., Cavet, M., Hirst, B. H. & Simmons, N. L. (1995) Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 114: 981-986.
14. Kramer, W., Girbig, F., Gutjahr, U., Kleemann, H. W., Leipe, I., Urbach, H. & Wagner, A. (1990) Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics. Biochim. Biophys. Acta 1027: 25-30.
15. Chu, X. Y., Sanchez-Castano, G. P., Higaki, K., Oh, D. M., Hsu, C. P. & Amidon, G. L. (2001) Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. J. Pharmacol. Exp. Ther. 299: 575-582.
16. Liang, R., Fei, Y. J., Prasad, P. D., Ramamoorthy, S., Han, H., Yang-Feng, T. L., Hediger, M. A., Ganapathy, V. & Leibach, F. H. (1995) Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270: 6456-6463.
17. Walker, D., Thwaites, D. T., Simmons, N. L., Gilbert, H. J. & Hirst, B. H. (1998) Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J. Physiol. 507: 697-706.
18. Thamotharan, M., Bawani, S. Z., Zhou, X. & Adibi, S. A. (1999) Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am. J. Physiol. 276: C821-C826.
19. Buyse, M., Berlioz, F., Guilmeau, S., Tsocas, A., Voisin, T., Peranzi, G., Merlin, D., Laburthe, M., Lewin, M. J., Roze, C. & Bado, A. (2001) PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J. Clin. Invest. 108: 1483-1494.
20. Watson, A. J., Levine, S., Donowitz, M. & Montrose, M. H. (1992) Serum regulates Na+/H+ exchange in Caco-2 cells by a mechanism which is dependent on F-actin. J. Biol. Chem. 267: 956-962.
21. Achler, C., Filmer, D., Merte, C. & Drenckhahn, D. (1989) Role of microtubules in polarized delivery of apical membrane proteins to the brush border of the intestinal epithelium. J. Cell Biol. 109: 179-189.
22. Nielsen, C. U. & Brodin, B. (2003) Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions. Curr. Drug Targets 4: 373-388.
23. Naruhashi, K., Sai, Y., Tamai, I., Suzuki, N. & Tsuji, A. (2002) PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine. Pharm. Res. 19: 1417-1423.